Medical Research Funding
Partnerships and Initiatives
We encourage collaboration across the various stakeholders in academia, government, industry, and philanthropic organizations to accelerate the development of new treatments for tauopathies. To expedite the development of new treatments for tauopathies, we promote collaboration among stakeholders from academia, government, industry, and philanthropic organizations. Please reach out to us at medgrants@rainwatercf.org if you would like to learn more about partnering with us.
Some of our collaborative initiatives are linked below:
- Biomarker Accelerator Program with CurePSP
- Biomarkers Consortium – Neurofilament as a Blood-Based Biomarker of Neurodegeneration in FTD with the Foundation for the National Institutes of Health
- FTD Diagnostic Biomarkers Initiative with the AFTD
- FTD Disorders Registry
- Neurofilament Light Surveillance Project (NSP) with the Bluefield Project
- Pathway and Pipeline Grant Program with CurePSP
- Philanthropic Investments in PET Tracers (PIPETTE) with the Michael J. Fox Foundation
- Prime of Life Brain Initiative and the PSP Genetics Consortium with CurePSP
- Tauopathy Challenge Workshop facilitated by The Rainwater Charitable Foundation
- The Tau Pipeline Enabling Program (T-PEP) with the Alzheimer’s Association
